beta
Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc.

PLRXBATSShares

$1.210

-$0.090

-7.20%

30 Jun 20:00

$1.100

$16.100

52 weeks low/high

Technical analysis

  • Trend Class
    Flat and Down
  • Trend Power
    Strong trend
  • Pattern
    Convergence channel
  • EMA-20
    Bearish reversal
    2025-06-11 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.
  • EMA-50
    Bearish reversal
    2025-02-06 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.
  • EMA-100
    Bearish reversal
    2025-01-08 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.
  • Stochastic
    Bullish reversal
    The stochastic indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: exit from the oversold zone.
  • RSI
    Bearish Weakening
    RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.
  • MACD
    Bearish Weakening
    Oscillator MACD is in the negative territory it's lower than the signal line and grows. These factors mean that the falling trend persists, but the growth rate is declining. Last signal: signal line crossed the middle level.
  • Candle pattern type
    Doji
    Is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
    Date of signal:

Prices and risks

Price

ChangeChange by industryMin.Max.Volume
Yesterday12.40%0.53%$1.230$1.290463.54K
Week12.40%1.73%$1.230$1.43011.16M
Month4.08%5.36%$1.230$1.69531.71M
3 Months8.08%2.78%$1.100$1.72079.31M
6 Months-89.08%15.89%$1.100$13.710428.27M
Year-86.94%21.29%$1.100$16.100895.08M
3 years-82.41%63.09%$1.100$36.6405.93B
5 years-95.69%103.15%$1.100$43.9206.82B
All time-91.24%59.33%$1.100$43.9207.00B

Volatility

PLRXBy industry
Yesterday25.12%0.76%
Week2.87%1.96%
Month17.32%11.61%
3 Months26.94%23.65%
6 Months42.51%29.79%
Year116.12%38.55%
3 years146.64%81.85%
5 years181.52%114.75%
All time——

Risk ratios

Sortino
-0.62
Sharpe
-0.75
Sterling
-0.94
Liquidity index
5.18
Alpha
0.00239
Beta
1.05
Indicators are given for the year

Fundamental analysis

Indicators for the last quarter and their dynamics for 5 quarters

Ratios

Valuation
P/E
0.00
Price/Sales
138.20
P/B
2.31
P/FCF
0.00
Debts
D/E
0.08
Efficiency
ROE
-40.95
ROA
-35.96
Net Worth
0.83
Quick Ratio
0.00
Current Ratio
14.47
Other ratios
Net Profit Margin
-3.63K
Operating Margin
-3.95K
Gross Margin
100.00
Return on tangible equity
-40.95
Revenue
EPS
0.95
EPS Forecast
0.99
Revenue
0.00
Gross Profit
0.00
EBITDA
-60.00M

Financials

Growth
Net Income
-$56.00M
Operating Income
-$61.00M
Assets
Total Assets
$484.00M
Cash on Hand
$437.00M
Total share holder equity
$393.00M
Debts
Long Term Debt
$30.00M
Total liabilities
$91.00M

News

Monday Sector Laggards: Biotechnology, Drugswww.nasdaq.comPliant Therapeutics Pauses Enrollment And Dosing In BEACON-IPF Trial, Stock In Freefallwww.nasdaq.comPliant Therapeutics Pauses Enrollment and Dosing in BEACON-IPF Phase 2b Trial Following DSMB Recommendationwww.nasdaq.comPLRX Makes Bullish Cross Above Critical Moving Averagewww.nasdaq.comHC Wainwright & Co. Maintains Pliant Therapeutics (PLRX) Buy Recommendationwww.nasdaq.comNeedham Reiterates Pliant Therapeutics (PLRX) Buy Recommendationwww.nasdaq.comWhy Shares of Pliant Therapeutics Are Rising Tuesdaywww.nasdaq.comPliant Therapeutics: Bexotegrast INTEGRIS-PSC Interim Data Surpasses Expectationswww.nasdaq.comHC Wainwright & Co. Reiterates Pliant Therapeutics (PLRX) Buy Recommendationwww.nasdaq.comJP Morgan Maintains Pliant Therapeutics (PLRX) Overweight Recommendationwww.nasdaq.com